Expression of tumor-rejection antigens in gynecologic cancers
about
p110, a novel human U6 snRNP protein and U4/U6 snRNP recycling factorBiosynthesis of dermatan sulfate: chondroitin-glucuronate C5-epimerase is identical to SART2Tip110 Regulates the Cross Talk between p53 and Hypoxia-Inducible Factor 1α under Hypoxia and Promotes Survival of Cancer Cells.Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles.
P2860
Expression of tumor-rejection antigens in gynecologic cancers
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Expression of tumor-rejection antigens in gynecologic cancers
@ast
Expression of tumor-rejection antigens in gynecologic cancers
@en
Expression of tumor-rejection antigens in gynecologic cancers
@nl
type
label
Expression of tumor-rejection antigens in gynecologic cancers
@ast
Expression of tumor-rejection antigens in gynecologic cancers
@en
Expression of tumor-rejection antigens in gynecologic cancers
@nl
prefLabel
Expression of tumor-rejection antigens in gynecologic cancers
@ast
Expression of tumor-rejection antigens in gynecologic cancers
@en
Expression of tumor-rejection antigens in gynecologic cancers
@nl
P2093
P2860
P1476
Expression of tumor-rejection antigens in gynecologic cancers
@en
P2093
M Sakamoto
S Shichijo
T Hashimoto
P2860
P304
P356
10.1111/J.1349-7006.2000.TB00902.X
P407
P577
2000-11-01T00:00:00Z